DocuSign's Buyback Is Paying the Bill Its Core Can't

The name is a confession. "DocuSign" is two words — document, signature — the promise that a piece of paper, once signed, closes a deal. That identity built a billion users and a household brand. Then on September 3, when DocuSign reported its fiscal-second-quarter results, the number it most wanted you to see had nothing to do with documents. "Intelligent Agreement Management" — the internal code for its AI makeover — had climbed to 15.1% of its recurring revenue, and management promised to push it toward a fifth of the business by January. A company whose ticker is DOCU is asking you to believe the document is no longer the point.

There are two DocuSigns inside one company, and they want the same thing: the market's permission to keep its valuation. The first is a mature cash cow — the e-signature business that still generates about 85% of revenue and is openly decelerating. The second is the growth story, an AI platform that handles the whole life of an agreement the way the old product only handled the final click. One funds the future; the other must justify the stock price while it arrives. The question is which self is paying for which.

The cash cow's invoice

The legacy business still prints money. Free cash flow hit about $296 million in the quarter, up roughly 35% from a year earlier, a margin near 34%. By that measure DocuSign looks like a machine at the end of its growth, the kind that returns cash instead of reinvesting it.

But look at how the profit number arrived. Adjusted earnings per share rose 26% year over year to $1.16. The top line did almost none of the work: revenue grew just 9% to $875.7 million. The 26% came mostly from a shrinking share count. DocuSign repurchased about $307 million of stock in the quarter, roughly $625 million across the first half, cutting diluted shares 8% to around 193 million and leaving $2.1 billion in remaining authorization. Buybacks, not customers, delivered the earnings growth. On the compensation sheet of this company, the tightening came from the buyback, not the business.

This is the hidden payer. The decelerating core produces a single-digit growth rate that, on its own, would buy a modest multiple. Buybacks convert that weak top line into a 26% EPS jump — the earnings trajectory a growth story is expected to show. The cash cow is underwriting the impression that DocuSign is still the kind of company whose shares can climb.

What the future actually costs

Now the other DocuSign. IAM — the rebranded platform that analyzes, drafts, and automates agreements with AI — reached 15.1% of total annual recurring revenue, up from 10.8% at the end of the fiscal year. Management says IAM will be 18% to 19% of ARR by the time fiscal 2027 ends. Customers have pushed more than 300 million documents through the platform's Agreement Manager.

The arithmetic here is quietly important. If IAM is heading toward roughly a fifth of ARR by January, and total growth is guided to stay near 9%, then the legacy ~85% of the business must be slowing enough to keep the blended number in the single digits. The future is real and it's growing — but the present it is replacing is shrinking, and the two nearly cancel out. DocuSign's own full-year guidance for this fiscal year, a revenue range of roughly $3.5 billion, implies about 9% growth. The growth story is being propped up by the same buyback mechanism on the other side of the house.

The tension is not that either self is a fraud. It's that both are true at once, and the market has to choose which one carries the multiple. The stock trades near $66, up about 38% over the past four months and 13% in the last three weeks, after clawing back from a 52-week low of $40.16. Yet it remains below a high of $86.65 and is slightly down for the year. Investors have angled toward the AI story without fully forgiving the company for being a document company first. Two valuations are bidding on the same shares — the cash cow's buyback-supported earnings and the AI platform's promised reacceleration.

Who receives the bill

DocuSign raised its own guidance for the year on revenue, ARR, and IAM's share of the business — the confidence of a company that believes its two selves can finally converge. But buybacks have limits. Every repurchase shrinks the float and raises EPS, yet each dollar returns progressively less as the share count falls and the price rises. And the core, meanwhile, is decelerating on schedule, doing the work that keeps IAM's growth from showing up in the blended number.

The two selves are paying each other's way: the cash cow finances the buyback that makes the top line look like growth, while the AI story gives the market a reason not to price the cash cow at a cash cow's multiple. The bill comes due when one stops cooperating — when the core slows faster than IAM can cover it, or when the buyback's arithmetic can no longer lift EPS by a quarter the way eight-point share-count cuts did this time. Then the market will have to decide, on the evidence, whether the company is a 9%-growth cash cow or an AI platform still waiting to be more than a fifth of itself. Neutrality won't survive that meeting.